Genetic association maps can guide mechanistic experiments, but a risk locus is not a therapy.
Primary research / authoritative source: https://www.nature.com/articles/s41586-026-11206-y
An association locus identifies a genomic region linked statistically with disease risk, not necessarily a single causal gene.
Analyzing diverse populations can improve locus discovery and test whether effects transfer across genetic backgrounds.
Genetic signals may implicate immune-cell pathways; functional experiments must establish how these pathways influence disease.
Neuronal pathways may appear alongside immune biology, suggesting interacting mechanisms rather than a single cause.
Fine-mapping, expression data and perturbation experiments help prioritize causal variants and genes.
Relative genetic risk differs from absolute lifetime risk and does not determine an individual diagnosis.
Targets require evidence of modifiable mechanisms, delivery feasibility, safety and clinical benefit.
A defensible incubator links reproducible genetic signals to cell models, perturbation and decision gates.